Interactions between angiotensin II and nitric oxide during exercise in normal and heart failure rats

Journal of Applied Physiology

Volumn 87, Issue 2, 1999, Pages 574-581

  Symons, J David ^a   Stebbins, Charles L ^a   Musch, Timothy I ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Losartan; N(G) intro L arginine methyl ester; Regional blood flow; Vascular conductance; Vascular resistance

Indexed keywords

ANGIOTENSIN; LOSARTAN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONDUCTANCE; EXERCISE; FEMALE; HEART FAILURE; HYPOTHESIS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKELETAL MUSCLE; TREADMILL EXERCISE;

EID: 0032819320     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1999.87.2.574     Document Type: Article

References (42)

1. Aaker, A., J. G. McCormack, T. Hirai, and T. I. Musch. Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction. J. Cardiovasc. Pharmacol. 28: 353-362, 1996.
2. Baylis, C., R. Braith, B. R. Santymire, and K. Engles. Renal nerves do not mediate vasoconstrictor responses to acute nitric oxide synthesis inhibition in conscious rats. J. Am. Soc. Nephrol. 8: 887-892, 1997.
3. Baylis, C., J. Harvey, and K. Engels. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin II. J. Am. Soc. Nephrol. 5: 211-214, 1994.
4. Booke, M., R. Waurick, H. Van Aken, H. G. Bone, A. Meissner, T. Prien, and J. Meyer. Effects of sympathetic nerve blockade on vasoconstrictive properties of nitric oxide inhibition in sheep. Cardiovasc. Res. 36: 111-117, 1997.
5. Delp, M. D., C. Duan, J. P. Mattson, and T. I. Musch. Changes in skeletal muscle biochemistry and histology relative to fiber type in rats with heart failure. J. Appl. Physiol. 83: 1291-1299, 1997.
6. Deng, X., W. J. Welch, and C. S. Wilcox. Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics. Hypertension 27: 1173-1179, 1996.
7. Drexler, H. Endothelial function in heart failure: some unsolved issues. Eur. Heart J. 17: 1775-1777, 1996.
8. Drexler, H., D. Hayoz, T. Munzel, H. Just, R. Zelis, and H. R. Brunner. Endothelial function in congestive heart failure. Am. Heart J. 126: 761-764, 1993.
9. Flaim, S. F., S. H. Nellis, E. J. Toggart, H. Drexler, K. Kanda, and E. D. Newman. Multiple simultaneous determinations of hemodynamics and flow distribution in conscious rats. J. Pharmacol. Methods 11: 1-39, 1984.
10. Garner, M. G., A. F. Phippard, P. J. Fletcher, J. M. MacLean, G. G. Duggin, J. S. Horvath, and D. J. Tiller. Effect of angiontensin II on baroreceptor reflex control of heart in conscious baboons. Hypertension 10: 628-634, 1987.
11. Glantz, S. A. Primer of Biostatistics (2nd ed.). New York: McGraw-Hill, 1987.
12. Hennington, B. S., H. Zhang, M. T. Miller, J. P. Granger, and J. F. Reckelhoff. Angiotensin II stimulates synthesis of endothelial nitric oxide synthase. Hypertension 31: 283-288, 1998.
13. Heymann, M. A., B. D. Payne, J. I. E. Hoffman, and A. M. Rudolph. Blood flow measurements with radionuclide-labeled particles. Prog. Cardiovasc. Dis. 20: 55-79, 1977.
14. Hirai, T., T. I. Musch, D. A. Morgan, K. C. Kregel, D. E. Classen, J. G. Pickar, S. J. Lewis, and M. J. Kenny. Differential sympathetic nerve responses to nitric oxide synthase inhibition in anesthetized rats. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R807-R813, 1995.
15. Hirai, T., M. D. Visneski, K. J. Kearns, R. Zelis, and T. I. Musch. Effects of NO synthase inhibition on the muscular blood flow response to treadmill exercise in rats. J. Appl. Physiol. 77: 1288-1293, 1994.
16. Hirai, T., R. Zelis, and T. I. Musch. Effects of nitric oxide synthase inhibition on the muscle blood flow response to exercise in rats with heart failure. Cardiovasc. Res. 30: 469-476, 1995.
17. Ikenaga, H., R. W. Fallet, and P. K. Carmines. Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F365-F373, 1996.
18. Kinugawa, T., K. Ogino, H. Kitamura, M. Saitoh, H. Omodani, S. Osaki, I. Hisatome, and H. Miyakoda. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure. Am. J. Med. Sci. 312: 110-117, 1996.
19. Laughlin, M. H., R. B. Armstrong, J. White, and K. Rouk. A method for using microspheres to measure muscle blood flow in exercising rats. J. Appl. Physiol. 52: 1629-1635, 1982.
20. Levine, T. B., G. S. Francis, S. R. Goldsmith, A. Simon, and J. N. Cohn. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am. J. Cardiol. 49: 1659-1666, 1982.
21. Matsukawa, S., and I. A. Reid. Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II. Circ. Res. 67: 1462-1473, 1990.
22. Matsumoto, A., Y. Hirata, and S. Momomura. Increased nitric oxide production during exercise. Lancet 343: 849-850, 1994.
23. Musch, T. I., R. L. Moore, D. J. Leathers, A. Bruno, and R. Zelis. Endurance training in rats with chronic heart failure induced by myocardial infarction. Circulation 74: 431-441, 1986.
24. Musch, T. I., R. L. Moore, P. G. Smaldone, M. Riedy, and R. Zelis. Cardiac adaptations to endurance training in rats with a chronic myocardial infarction. J. Appl. Physiol. 66: 712-719, 1989.
25. Musch, T. I., and J. A. Terrell. Skeletal muscle blood flow abnormalities in rats with a chronic myocardial infarction: rest and exercise Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H411-H419, 1992.
26. O'Leary, D. S. Regional vascular resistance vs. conductance: which index for baroreflex responses? Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H632-H637, 1991.
27. Parekh, N., L. Dobrowolski, A-.P. Zou, and M. Steinhausen. Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R630-R635, 1996.
28. Rowell, L. B. Human Cardiovascular Control. New York: Oxford Univ. Press, 1986, p. 99.
29. 1 receptors. Hypertens. Res. 19: 201-206, 1996.
30. G-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in central regulation of sympathetic tone. Circ. Res. 70: 607-611, 1992.
31. Sbarouni, E., A. Bradshaw, F. Andreotti, E. Tuddenham, C. M. Oakley, and J. G. F. Cleland. Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure. Am. Heart J. 127: 607-612, 1994.
32. Smith, R. D., A. T. Chiu, P. C. Wong, W. F. Herblin, and P. B. M. W. M. Timmermans. Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu. Rev. Pharmacol. Toxicol. 32: 135-165, 1992.
33. Stebbins, C. L., and J. D. Symons. Vasopressin contributes to the cardiovascular response to dynamic exercise. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1701-H1707, 1993.
34. Stebbins, C. L., and J. D. Symons. Role of angiotensin II in the hemodynamic response to dynamic exercise in the miniswine. J. Appl. Physiol. 78: 185-190, 1995.
35. Stebbins, C. L., J. D. Symons, M. D. McKirnan, and F. W. Hwang. Factors associated with vasopressin release in exercising swine. Am. J. Physiol. 266 (Regulatory Integrative Comp. Physiol. 35): R118-R124, 1994.
36. Sumino, H., K. Sato, T. Sakamaki, H. Masuda, T. Nakamura, T. Kanda, and R. Nagai. Decreased basal production of nitric oxide in patients with heart disease. Chest 113: 317-322, 1998.
37. Swedberg, K., P. Eneroth, J. Kjekshus, and L. Wilhelmsen for the CONSENSUS trial study group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 82: 1730-1736, 1990.
38. Symons, J. D., T. I. Musch, K. S. Hageman, and C. L. Stebbins. Nitric oxide attenuates angiotensin II-induced increases in vascular resistance. J. Cardiovasc. Pharmacol. 34: 116-123, 1999.
39. Symons, J. D., and C. L. Stebbins. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin. J. Cardiovasc. Pharmacol. 28: 223-231, 1996.
40. Symons, J. D., C. L. Stebbins, and J. C. Longhurst. Response of collateral-dependent myocardium to vasopressin release during exercise. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1644-H1652, 1993.
41. Symons, J. D., C. L. Stebbins, and T. I. Musch. Nitric oxide attenuates the pressor activity of angiotensin II during exercise (Abstract). Physiologist 39: A-42, 1996.
42. Tidgren, B, P. Hjemdahl, E. Theodorsson, and J. Nussberger. Renal neurohormonal and vascular responses to dynamic exercise in humans. J. Appl. Physiol. 70: 2279-2286, 1991.